Sign up
Pharma Capital
EPIC: AKR
Market: AIM
52-week High/Low: 85.00p / 10.50p
Sector: Health Care, Equipment & Services
Market Cap: 19.29M
Website: www.akersbio.com

Akers Biosciences, Inc. develops, manufactures, and distributes rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician.  We have developed several proprietary platform technologies that provide us with product development flexibility.  Our goal is to always deliver accurate, single-patient results in a time- and...

Akers Biosciences, Inc.

www.akersbio.com

Interactive graph

col 3
col 4
col 5
col 6
View full AKR profile View Profile
View All

Market Reports Including AKR

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.